Surgery Doctors in Morganton, NC Accepting Medicare

5 Surgery doctors found. Showing 1 - 5

Dr. John Smith Berry Iv, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 2209 S Sterling St Ste 530, Morganton, NC 28655 Phone: 828-580-2250    Fax: 828-580-2252

Dr. Leonidas Athanasios Goudas, MD Surgery Medicare: Medicare Enrolled Practice Location: 300 Enola Rd, Morganton, NC 28655 Phone: 828-608-6360    Fax: 828-433-2735

Dr. Edwin Hobbs Holler, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 500 E Parker Rd, Morganton, NC 28655 Phone: 828-430-9566    Fax: 828-430-9935

Eric Tavis Sevensma, D.O. Surgery Medicare: Accepting Medicare Assignments Practice Location: 2209 S Sterling St Ste 600, Morganton, NC 28655 Phone: 828-580-2250    Fax: 828-580-2252

Rowan Richard Andrew Sheldon, MD Surgery Medicare: Medicare Enrolled Practice Location: 2209 S Sterling St Ste 530, Morganton, NC 28655 Phone: 828-580-2250    Fax: 828-580-2252

News Archive

Poll shows Obama leading in Virginia despite mixed feelings about the health law

Virginia is viewed as one of the hot states in the presidential campaign. Also, because female voters continue to be considered an important force in the upcoming election, women's health issues are getting a lot of air time.

Femoro-acetabular impingement may not always cause osteoarthritis in some racial groups

Osteoarthritis is the most common joint disorder worldwide, yet the cause of osteoarthritis of the hip is still unknown.

Study: Targeted biopsy technique better than standard biopsy at detecting high-risk prostate cancer

Among men undergoing biopsy for suspected prostate cancer, targeted magnetic resonance/ultrasound fusion biopsy, compared with a standard biopsy technique, was associated with increased detection of high-risk prostate cancer and decreased detection of low-risk prostate cancer, according to a study in the January 27 issue of JAMA.

State actions on human papillomavirus vaccine proposals

The following highlights recent news of state actions on human papillomavirus vaccine proposals. Merck's HPV vaccine Gardasil and GlaxoSmithKline's HPV vaccine Cervarix in clinical trials have been shown to be 100% effective in preventing infection with HPV strains 16 and 18, which together cause about 70% of cervical cancer cases.

New standards for public involvement in research launched across the UK

A set of national standards designed to improve the quality and consistency of public involvement in research launch today at the 2018 Patients First conference - hosted jointly by the AMRC and the ABPI - and at the Involving People Network Annual Meeting 2018.

Read more Medical News

› Verified 5 days ago